Clinical development and approval of COVID-19 vaccines-Reference-Cited by-同舟云学术

Clinical development and approval of COVID-19 vaccines

Published:2022-03-14 Issue:5 Volume:21 Page:609-619
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Kalinke Ulrich¹²,Barouch Dan H.³,Rizzi Ruben⁴,Lagkadinou Eleni⁴,Türeci Özlem⁴,Pather Shanti⁴,Neels Pieter⁵

Affiliation:

1. Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany

2. Cluster of Excellence - Resolving Infection Susceptibility (Resist, Exc 2155), Hannover Medical School, Hannover, Germany

3. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

4. BioNTech SE, Mainz, Germany

5. Vaccine Advice BV, Belgium

Funder

Medical Communications agency Scion

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2042257

Reference99 articles.

1. World Health Organization. Coronavirus Disease (COVID-19). Press Conference, 28 February 2020 [Internet]. [cited 2022 Feb 10]. Available from: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-28feb2020.pdf?sfvrsn=13eeb6a4_2

2. World Health Organization. WHO director-general’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [cited 2022 Feb 10]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

3. Evolution of the COVID-19 vaccine development landscape

4. US Food and Drug Administration. Emergency Use Authorization (EUA) for an unapproved product review memorandum. Application 27034 [Internet]. [cited 2022 Feb 10]. Available from: https://www.fda.gov/media/144416/download

5. US Food and Drug Administration. Emergency Use Authorization (EUA) for an unapproved product review memorandum. Application 27073 [Internet]. [cited 2022 Feb 10]. Available from: https://fda.report/media/144673/Moderna+COVID-19+Vaccine+review+memo.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations;Frontiers in Immunology;2024-01-31

2. The Community Pharmacy as a Study Center for the Epidemiological Analysis of the Population Vaccination against SARS-CoV-2: Evaluation of Vaccine Safety and Pharmaceutical Service;Pharmacy;2024-01-20

3. Impact of COVID-19 vaccination: a global perspective;Frontiers in Public Health;2024-01-11

4. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines;Vaccines;2024-01-06

5. COVID-19 human challenge trials and randomized controlled trials: lessons for the next pandemic;Research Ethics;2024-01-03